These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 20190589)
1. Herpes zoster among HIV-infected patients in the highly active antiretroviral therapy era: Korean HIV cohort study. Song JY; Lee JS; Jung HW; Choi HJ; Lee JS; Eom JS; Cheong HJ; Jung MH; Kim WJ J Acquir Immune Defic Syndr; 2010 Mar; 53(3):417-8. PubMed ID: 20190589 [No Abstract] [Full Text] [Related]
2. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era. Moanna A; Rimland D Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391 [TBL] [Abstract][Full Text] [Related]
3. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714 [TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Shearer K; Maskew M; Ajayi T; Berhanu R; Majuba P; Sanne I; Fox MP Int J Infect Dis; 2014 Jun; 23():56-62. PubMed ID: 24680820 [TBL] [Abstract][Full Text] [Related]
5. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort. Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O; Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456 [TBL] [Abstract][Full Text] [Related]
6. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. Gebo KA; Kalyani R; Moore RD; Polydefkis MJ J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734 [TBL] [Abstract][Full Text] [Related]
7. Comparison of HIV-infected patients' characteristics and clinical outcomes between cohort-dependent and independent patients: Korean HIV cohort study. Song JY; Lee JS; Jeong HW; Choi HJ; Lee JS; Lee J; Eom JS; Cheong HJ; Chung MH; Kim WJ J Acquir Immune Defic Syndr; 2011 Jul; 57(3):e61-3. PubMed ID: 21860352 [No Abstract] [Full Text] [Related]
8. The incidence of herpes zoster is less likely than other opportunistic infections to be reduced by highly active antiretroviral therapy. Vanhems P; Voisin L; Gayet-Ageron A; Trepo C; Cotte L; Peyramond D; Chidiac C; Touraine JL; Livrozet JM; Fabry J; Voirin N J Acquir Immune Defic Syndr; 2005 Jan; 38(1):111-3. PubMed ID: 15608535 [No Abstract] [Full Text] [Related]
9. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan. Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine. Nacher M; Basurko C; Adenis A; Gaubert-Marechal E; Mosnier E; Edouard S; Vantilcke V; Sivapregassam S; Tressières B; Cabié A; Couppié P PLoS One; 2013; 8(11):e80187. PubMed ID: 24244647 [TBL] [Abstract][Full Text] [Related]
11. Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study. Glesby MJ; Hoover DR; Tan T; Shi Q; Gao W; French AL; Maurer T; Young M; Dehovitz J; Ru J; Anastos K J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1604-9. PubMed ID: 15577417 [TBL] [Abstract][Full Text] [Related]
12. HIV-positive patient with herpes zoster: a manifestation of the immune reconstitution inflammatory syndrome. Lutwak N; Dill C Am J Emerg Med; 2012 Jan; 30(1):254.e3-5. PubMed ID: 21129888 [TBL] [Abstract][Full Text] [Related]
13. Herpes zoster among persons living with HIV in the current antiretroviral therapy era. Blank LJ; Polydefkis MJ; Moore RD; Gebo KA J Acquir Immune Defic Syndr; 2012 Oct; 61(2):203-7. PubMed ID: 22766968 [TBL] [Abstract][Full Text] [Related]
14. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Wood SM; Shah SS; Steenhoff AP; Rutstein RM Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820 [TBL] [Abstract][Full Text] [Related]
15. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Domingo P; Torres OH; Ris J; Vazquez G Am J Med; 2001 Jun; 110(8):605-9. PubMed ID: 11382367 [TBL] [Abstract][Full Text] [Related]
16. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460 [TBL] [Abstract][Full Text] [Related]
17. Images in HIV/AIDS. Keloid after herpes zoster in an HIV-infected person. Castro JG; Espinoza L AIDS Read; 2009 May; 19(5):187-8. PubMed ID: 19554738 [No Abstract] [Full Text] [Related]
18. Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome. Espinosa E; Peña-Jiménez A; Ormsby CE; Vega-Barrientos R; Reyes-Terán G HIV Med; 2009 Aug; 10(7):454-7. PubMed ID: 19490175 [TBL] [Abstract][Full Text] [Related]
19. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination. Aziz M; Kessler H; Huhn G Int J STD AIDS; 2013 Jun; 24(6):433-9. PubMed ID: 23970744 [TBL] [Abstract][Full Text] [Related]